Ramiprilat diketopiperazine

CAS : 108736-10-3

Ref. 3D-FR27679

Informations sur le produit

• Nom: Ramiprilat diketopiperazine
• Synonymes: [3S-[2(R*),3a,5a-b,8a-b,9a-b]]-Decahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic acid, [3S-[2(R*),3a,5ab,8ab,9ab]]-Decahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid, [3S-[2(R*),3a,5a,8a,9a]]-Decahydro-3-methyl-1,4-dioxo-a-(2-phenylethyl)-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazine-2-acetic Acid

Description

Ramiprilat diketopiperazine is a drug that is metabolized by glucuronidation. It is an analog of ramipril, which is a member of the angiotensin-converting enzyme (ACE) inhibitors. Ramiprilat diketopiperazine has been shown to be clinically effective in reducing blood pressure and improving left ventricular function in patients with chronic heart failure. The reanalysis and validation of the bioanalytical method for analysis of ramiprilat diketopiperazine have been completed, and the method was validated for use in clinical studies. The analytes were measured using chromatography with ultraviolet detection or with liquid chromatography-mass spectrometry-mass spectrometry. The method development for the analysis of glucuronide metabolites has also been completed, and these metabolites were quantified using high performance liquid chromatography with UV detection or with gas chromatography-mass spectrometry-mass spectrometry.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 370.44 g/mol
• Formule: C₂₁H₂₆N₂O₄
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C21H26N2O4/c1-13-19(24)23-16-9-5-8-15(16)12-18(23)20(25)22(13)17(21(26)27)11-10-14-6-3-2-4-7-14/h2-4,6-7,13,15-18H,5,8-12H2,1H3,(H,26,27)/t13-,15-,16-,17-,18-/m0/s1
• Code InChI: InChIKey=DZRWPCCIYKIPJW-HILJTLORSA-N
• SMILES: C[C@H]1C(=O)N2[C@@H](C[C@@H]3CCC[C@@H]32)C(=O)N1[C@@H](CCc1ccccc1)C(=O)O